Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Bram L. T. Ramaekers; Robert F. Wolff; Xavier Pouwels; Marije Oosterhoff; Anoukh Van Giessen; Gill Worthy; Caro Noake; Nigel Armstrong; Jos Kleijnen; Manuela A. Joore

doi:10.1007/s40273-018-0629-2

Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Bram L. T. Ramaekers^*, Robert F. Wolff, Xavier Pouwels, Marije Oosterhoff, Anoukh Van Giessen, Gill Worthy, Caro Noake, Nigel Armstrong, Jos Kleijnen, Manuela A. Joore

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	917-927
Number of pages	11
Journal	Pharmacoeconomics
Volume	36
Issue number	8
DOIs	https://doi.org/10.1007/s40273-018-0629-2
Publication status	Published - 1 Aug 2018

Access to Document

10.1007/s40273-018-0629-2

https://link.springer.com/content/pdf/10.1007%2Fs40273-018-0629-2.pdf

Cite this

Ramaekers, Bram L. T. ; Wolff, Robert F. ; Pouwels, Xavier ; Oosterhoff, Marije ; Van Giessen, Anoukh ; Worthy, Gill ; Noake, Caro ; Armstrong, Nigel ; Kleijnen, Jos ; Joore, Manuela A. / Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. In: Pharmacoeconomics. 2018 ; Vol. 36, No. 8. pp. 917-927.

@article{6ab389ced1f14b748f36081fcbe0323c,

title = "Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",

author = "Ramaekers, {Bram L. T.} and Wolff, {Robert F.} and Xavier Pouwels and Marije Oosterhoff and {Van Giessen}, Anoukh and Gill Worthy and Caro Noake and Nigel Armstrong and Jos Kleijnen and Joore, {Manuela A.}",

year = "2018",

month = aug,

day = "1",

doi = "10.1007/s40273-018-0629-2",

language = "English",

volume = "36",

pages = "917--927",

journal = "Pharmacoeconomics",

issn = "1170-7690",

publisher = "Adis International Ltd",

number = "8",

}

Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. / Ramaekers, Bram L. T.; Wolff, Robert F.; Pouwels, Xavier; Oosterhoff, Marije; Van Giessen, Anoukh; Worthy, Gill; Noake, Caro; Armstrong, Nigel; Kleijnen, Jos ; Joore, Manuela A.

In: Pharmacoeconomics, Vol. 36, No. 8, 01.08.2018, p. 917-927.

Research output: Contribution to journal › Review article › Academic › peer-review

TY - JOUR

T1 - Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

AU - Ramaekers, Bram L. T.

AU - Wolff, Robert F.

AU - Pouwels, Xavier

AU - Oosterhoff, Marije

AU - Van Giessen, Anoukh

AU - Worthy, Gill

AU - Noake, Caro

AU - Armstrong, Nigel

AU - Kleijnen, Jos

AU - Joore, Manuela A.

PY - 2018/8/1

Y1 - 2018/8/1

U2 - 10.1007/s40273-018-0629-2

DO - 10.1007/s40273-018-0629-2

M3 - Review article

C2 - 29480455

VL - 36

SP - 917

EP - 927

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 8

ER -